COVID-19 vaccines in patients with cancer

Lancet Oncol. 2021 Jun;22(6):738-739. doi: 10.1016/S1470-2045(21)00250-3.

Authors

Dario Trapani¹, Giuseppe Curigliano²

Affiliations

¹ European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.
² European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy; Department of Oncology and Hematology, University of Milan, Milan, Italy. Electronic address: [email protected].

No abstract available

Publication types

Comment

MeSH terms

BNT162 Vaccine
COVID-19 Vaccines
COVID-19*
Humans
Neoplasms* / therapy
Prospective Studies
SARS-CoV-2

Substances

COVID-19 Vaccines
BNT162 Vaccine